ANDHealth

Australia's only business accelerator dedicated to digital health commercialisation & investment readiness.
ANDHealth
Operating

ANDHealth is a national digital health initiative established by a consortium of commercial and government partners to facilitate and support the development & commercialisation of clinically validated digital health technologies across Australia. We are federally and commercially funded and will be focusing on working with mid-stage digital health projects on proof of concept and pivotal clinical validation, investment readiness and market entry - with a specific focus on regulated digital health technologies which have a clear impact on clinical outcomes for patients. Our Vision A world leading, national, integrated ecosystem for the development & commercialisation of evidence-based digital health technologies in Australia. Our Mission To create integrated and connected ecosystem for the development & commercialisation of evidence-based digital health products bringing together participants from the medtech and pharmaceutical sectors with a broader stakeholder group drawn from a wide range of sectors involved in the evolution of digital health technologies, and by putting in place the key elements required to create a cohesive and collaborative digital health industry.

Accelerated companies
2019
Startup

CancerAid

Startup

Health Delivered

Startup

iUFlow

Startup

Vitalic Medical

2018
Startup

Atmo Biosciences

Startup

MCRI AllergyPal

Startup

Perx Health

Startup

Seer Medical

Images
Taken on 2020-10
Blog Posts
23rd March, 2021
ANDHealth Announces New Partnership to Drive Change for Digital Therapeutics Companies

MEDIA RELEASE 24 March 2021 ANDHealth, Australia’s leading digital health commercialisation organisa...

11th March, 2021
ANDHealth Collaborates with US Healthcare Leader Anthem Inc. to Bring Innovative Australian Technologies to the US Market

MEDIA RELEASE 12 March 2021 ANDHealth, Australia’s leading organisation in the commercialisation of ...

20th January, 2021
TTRA Funding Opportunity for Diabetes and Cardiovascular Disease

The $38 million Targeted Translation Research Accelerator (TTRA) initiative is a four-year funding o...

2nd December, 2020
Meet one of Australia’s newest Superstars of STEM

Grace Lethlean, a passionate enabler of commercial potential in digital health has been named one of...

12th November, 2020
ANDHealth Announces FY21 Q1 Cohort Outcomes

ANDHealth, Australia’s leading organisation in accelerating the commercialisation of evidence-based ...

29th October, 2020
ANDHealth 2020 Annual Report Released

On behalf of the Board of Directors and Members, ANDHealth is delighted to present the 2020 annual r...

29th October, 2020
ANDHealth 2020 Annual Report Released

On behalf of the Board of Directors and Members, ANDHealth is delighted to present the 2020 annual r...

29th October, 2020
Leading Investor, Adviser and Entrepreneur Appointed to ANDHealth Board

Dr Charlie Day (D.Phil (Oxon), B.E. (Hons), B.A., GAICD) has been elected as a Non-Executive Directo...

16th October, 2020
ANDHealth Welcomes Focus on Translation & Commercialisation in Digital Health

HLTH KEYNOTE DEBRIEF | The Hon Greg Hunt MP, Minister for Health, Commonwealth of Australia Federal ...

13th October, 2020
Changes Afoot at ANDHealth

Bronwyn Le Grice | Founder, CEO, Managing Director, ANDHealth As we approach the end of the year I’m...

 Location
Melbourne
 People
No information available.
 Feedback